Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

The approvals are supported by the REAL8 study, which showed Sogroya was non‑inferior to daily growth hormone therapy across all three indications. Adverse reactions occurring in at least 10% of ...

In today’s Pharmaceutical Executive Daily, the FDA approves an expanded indication for Palynziq in patients aged 12 and older ...

At this year’s American Academy of Orthopedic Surgeons (AAOS) annual meeting, investigators at Hospital for Special Surgery ...

Ninety-five percent of adolescent athletes with lumbar spine stress fractures recovered without surgery, according to research from New York City-based Hospital for Special Surgery presented at the ...

Sermorelin.com Unveils Telehealth Peptide Treatment for Lean Mass Preservation Sheridan, United States - February 27, ...

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments. The study published in the International Journal of Molecular Science ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments. The study published in the International Journal of Molecular Science ...

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments. The study published ...

Sermorelin.com, a telehealth platform specializing in physician-supervised peptide therapy, today announced the launch of a ...